View Clinical Trial (Medical Research Study)
Characterization of Familial Myopathy and Paget Disease of Bone
| City: |
|
Irvine |
| State: |
|
California |
| Zip Code: |
|
92697 |
| Conditions: |
|
Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia - Paget Disease of Bone - Frontotemporal Dementia - Myopathy |
| Purpose: |
|
The investigators are researching families with inherited inclusion body myopathy (IBM)
and/or Paget disease of bone (PDB) and/or dementia (FTD) which is also called IBMPFD. IBMPFD
is caused by mutations in the VCP gene. Our main goal is to understand how changes in the
VCP gene cause the muscle, bone and cognitive problems associated with the disease.
The investigators are collecting biological specimen such as blood and urine samples, family
and medical histories, questionnaire data of patients with a personal or family history of
VCP associated disease. Participants do not need to have all symptoms listed above in order
to qualify. A select group of participants may be invited to travel to University of
California, Irvine for a two day program of local procedures such as an MRI and bone scan.
Samples are coded to maintain confidentiality. Travel is not necessary except for families
invited for additional testing.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Inclusion criteria include all individuals with a combination of medical problems
including muscle and bone disease and their family members. Because historically VCP
related muscle disease has been erroneously diagnosed with the following diagnoses,
therefore if these patients also have a personal or family history of bone disease
they will be considered eligible for the study:
Muscle disorders considered include:
- Limb Girdle Muscular Dystrophy
- Myopathy
- Inclusion body myopathy
- FSH (Facioscapular muscular dystrophy) without the mutation
- Scapuloperoneal muscular dystrophy
- Amyotrophic Lateral Sclerosis
- Non specific muscular dystrophy
AND
- Bone disorders including:
- Paget disease of bone
- Fibrous dysplasia
- Diaphyseal medullary stenosis with malignant fibrous histiocytoma (DMS-MFH)
- Non-specific bone disease
Eligible participants must also be:
- Subjects must to 18 years or older
- Subjects must to able to give consent
- Adult family members or spouses over the age of 18 of the affected individuals
Exclusion Criteria:
- Under the age of 18.
Individuals who report a different unrelated diagnosis will be excluded from the study.
Testing to confirm different diagnoses will not be performed, instead patient will be
questioned for this information and records will be obtained for confirmation of
appropriate testing.
Those who are unable to provide consent for themselves will be excluded from participating
in the study.
|
| NCT ID: |
|
NCT01353430 |
| Primary Contact: |
|
Principal Investigator
Virginia Kimonis, MD
University of California, Irvine
Sandra Donkervoort, MS, CGC
Phone: 949 824 0521
Email: sdonkerv@uci.edu
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Irvine, California 92697
United States
Sandra Donkervoort, MS CGC
Phone: 949-824-0521
Email: sdonkerv@uci.edu
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 25, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|